These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31731431)

  • 1. Development and Validation of a Reporter-Cell-Line-Based Bioassay for Therapeutic Soluble gp130-Fc.
    Yu L; Jia C; Yao W; Pei D; Qin X; Rao C; Wang J
    Molecules; 2019 Oct; 24(21):. PubMed ID: 31731431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alternative intronic polyadenylation generates the interleukin-6 trans-signaling inhibitor sgp130-E10.
    Sommer J; Garbers C; Wolf J; Trad A; Moll JM; Sack M; Fischer R; Grötzinger J; Waetzig GH; Floss DM; Scheller J
    J Biol Chem; 2014 Aug; 289(32):22140-50. PubMed ID: 24973212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure-guided optimization of the interleukin-6 trans-signaling antagonist sgp130.
    Tenhumberg S; Waetzig GH; Chalaris A; Rabe B; Seegert D; Scheller J; Rose-John S; Grötzinger J
    J Biol Chem; 2008 Oct; 283(40):27200-7. PubMed ID: 18650419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling.
    Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J
    J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel reporter gene assay for recombinant human erythropoietin (rHuEPO) pharmaceutical products.
    Yang Y; Zhou Y; Yu L; Li X; Shi X; Qin X; Rao C; Wang J
    J Pharm Biomed Anal; 2014 Nov; 100():316-321. PubMed ID: 25194345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL-6 trans-signaling system in intra-amniotic inflammation, preterm birth, and preterm premature rupture of the membranes.
    Lee SY; Buhimschi IA; Dulay AT; Ali UA; Zhao G; Abdel-Razeq SS; Bahtiyar MO; Thung SF; Funai EF; Buhimschi CS
    J Immunol; 2011 Mar; 186(5):3226-36. PubMed ID: 21282511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of humanized anti-IL-6R antibody, tocilizumab on the activity of soluble gp130, natural inhibitor of IL-6 signaling.
    Hashizume M; Mihara M
    Rheumatol Int; 2009 Feb; 29(4):397-401. PubMed ID: 18802703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a robust reporter gene-based assay for the bioactivity determination of recombinant human follicle stimulating hormone (rhFSH) pharmaceutical products.
    Wang LY; Liang CG; Yang HM; Li J; Li ZJ; Zhang H; Lv P; Li Y; Wang JZ
    J Pharm Biomed Anal; 2020 Jan; 177():112855. PubMed ID: 31561061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Soluble Forms of the Interleukin-6 Family Signal Transducer gp130 Fine-tune the Blockade of Interleukin-6 Trans-signaling.
    Wolf J; Waetzig GH; Chalaris A; Reinheimer TM; Wege H; Rose-John S; Garbers C
    J Biol Chem; 2016 Jul; 291(31):16186-96. PubMed ID: 27226573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring the bioactivity of anti-IL-6/anti-IL-6R therapeutic antibodies: presentation of a robust reporter gene assay.
    Yu C; Cao J; Wang L; Yang Y; Ni Y; Wang J
    Anal Bioanal Chem; 2018 Nov; 410(27):7067-7075. PubMed ID: 30178083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone.
    Yao W; Yu L; Fan W; Shi X; Liu L; Li Y; Qin X; Rao C; Wang J
    Molecules; 2019 Apr; 24(7):. PubMed ID: 30970583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses.
    Müller-Newen G; Küster A; Hemmann U; Keul R; Horsten U; Martens A; Graeve L; Wijdenes J; Heinrich PC
    J Immunol; 1998 Dec; 161(11):6347-55. PubMed ID: 9834125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a reliable cell-based reporter gene assay for measuring bioactivities of therapeutic anti-interleukin-23 monoclonal antibodies.
    Huang J; Wang L; Yu C; Fu Z; Liu C; Zhang H; Wang K; Guo X; Wang J
    Int Immunopharmacol; 2020 Aug; 85():106647. PubMed ID: 32504997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exclusive inhibition of IL-6 trans-signaling by soluble gp130
    Berg AF; Ettich J; Weitz HT; Krusche M; Floss DM; Scheller J; Moll JM
    Cytokine X; 2021 Dec; 3(4):100058. PubMed ID: 34927050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional expression of a biologically active fragment of soluble gp130 as an ELP-fusion protein in transgenic plants: purification via inverse transition cycling.
    Lin M; Rose-John S; Grötzinger J; Conrad U; Scheller J
    Biochem J; 2006 Sep; 398(3):577-83. PubMed ID: 16716147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate inhibits IL-6 synthesis and suppresses transsignaling by enhancing soluble gp130 production.
    Ahmed S; Marotte H; Kwan K; Ruth JH; Campbell PL; Rabquer BJ; Pakozdi A; Koch AE
    Proc Natl Acad Sci U S A; 2008 Sep; 105(38):14692-7. PubMed ID: 18796608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130.
    Narazaki M; Yasukawa K; Saito T; Ohsugi Y; Fukui H; Koishihara Y; Yancopoulos GD; Taga T; Kishimoto T
    Blood; 1993 Aug; 82(4):1120-6. PubMed ID: 8353278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related increased prevalence of asthma and nasal polyps in chronic rhinosinusitis and its association with altered IL-6 trans-signaling.
    Cho SH; Kim DW; Lee SH; Kolliputi N; Hong SJ; Suh L; Norton J; Hulse KE; Seshadri S; Conley DB; Kern RC; Tan BK; Peters A; Grammer LC; Schleimer RP
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):601-6. PubMed ID: 26266960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses.
    Jostock T; Müllberg J; Ozbek S; Atreya R; Blinn G; Voltz N; Fischer M; Neurath MF; Rose-John S
    Eur J Biochem; 2001 Jan; 268(1):160-7. PubMed ID: 11121117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of recombinant soluble IL-6-signal transducer, gp130, with a complex of IL 6 and soluble IL-6 receptor, and establishment of an ELISA for soluble gp130.
    Yasukawa K; Futatsugi K; Saito T; Yawata H; Narazaki M; Suzuki H; Taga T; Kishimoto T
    Immunol Lett; 1992 Feb; 31(2):123-30. PubMed ID: 1740350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.